Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.
Harrer DC, Menhart K, Mayer S, Herr W, Reichle A, Vogelhuber M. Harrer DC, et al. Front Oncol. 2020 Oct 2;10:585830. doi: 10.3389/fonc.2020.585830. eCollection 2020. Front Oncol. 2020. PMID: 33134180 Free PMC article.
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges.
Harrer DC, Dörrie J, Schaft N. Harrer DC, et al. Int J Mol Sci. 2019 Nov 26;20(23):5942. doi: 10.3390/ijms20235942. Int J Mol Sci. 2019. PMID: 31779130 Free PMC article. Review.
Production of Phytochromes by High-Cell-Density E. coli Fermentation.
Hörner M, Gerhardt K, Salavei P, Hoess P, Härrer D, Kaiser J, Tabor JJ, Weber W. Hörner M, et al. Among authors: harrer d. ACS Synth Biol. 2019 Oct 18;8(10):2442-2450. doi: 10.1021/acssynbio.9b00267. Epub 2019 Sep 26. ACS Synth Biol. 2019. PMID: 31526004
Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy.
Simon B, Harrer DC, Thirion C, Schuler-Thurner B, Schuler G, Uslu U. Simon B, et al. Among authors: harrer dc. J Immunol Methods. 2019 Sep;472:55-64. doi: 10.1016/j.jim.2019.06.015. Epub 2019 Jun 14. J Immunol Methods. 2019. PMID: 31207210
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia.
Harrer DC, Schuler G, Dörrie J, Schaft N. Harrer DC, et al. Int J Mol Sci. 2019 Jun 5;20(11):2764. doi: 10.3390/ijms20112764. Int J Mol Sci. 2019. PMID: 31195686 Free PMC article.
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer.
Simon B, Harrer DC, Schuler-Thurner B, Schuler G, Uslu U. Simon B, et al. Among authors: harrer dc. Cancers (Basel). 2019 May 20;11(5):696. doi: 10.3390/cancers11050696. Cancers (Basel). 2019. PMID: 31137488 Free PMC article.
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U. Simon B, et al. Among authors: harrer dc. Exp Dermatol. 2018 Jul;27(7):769-778. doi: 10.1111/exd.13678. Exp Dermatol. 2018. PMID: 29704887
Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race.
Harrer DC, Dörrie J, Schaft N. Harrer DC, et al. Hum Gene Ther. 2018 May;29(5):547-558. doi: 10.1089/hum.2017.236. Epub 2018 Feb 27. Hum Gene Ther. 2018. PMID: 29320890 Review.
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC, Simon B, Fujii SI, Shimizu K, Uslu U, Schuler G, Gerer KF, Hoyer S, Dörrie J, Schaft N. Harrer DC, et al. BMC Cancer. 2017 Aug 17;17(1):551. doi: 10.1186/s12885-017-3539-3. BMC Cancer. 2017. PMID: 28818060 Free PMC article.
Sleep and awareness about presence of regularity speed the transition from implicit to explicit knowledge.
Drosopoulos S, Harrer D, Born J. Drosopoulos S, et al. Among authors: harrer d. Biol Psychol. 2011 Mar;86(3):168-73. doi: 10.1016/j.biopsycho.2010.11.005. Epub 2010 Dec 14. Biol Psychol. 2011. PMID: 21163328
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page